Paul Greenlaw, MD
Orthopaedic Surgery · New Bern, NCNPI 1558320291
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $770 of the $1,265 with a category attached, or 60.9%. Smith+Nephew accounts for 71.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $816 and has fallen 98.7% since, to $11 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in NC, where the typical reported total is $4,547.
Across 21 payments — averaging $60.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$908
- Johnson & Johnson$96
- Stryker$74
- Clozex Medical Inc$61
- Linvatec Corporation$47
- Medacta USA, Inc.$41
- plus $38 from 3 others
What the payments were for
- Travel & lodging$49539%
- Food & beverage$77061%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 13 | $908 |
| Johnson & Johnson | 1 | $96 |
| Stryker | 1 | $74 |
| Clozex Medical Inc | 1 | $61 |
| Linvatec Corporation | 1 | $47 |
| Medacta USA, Inc. | 1 | $41 |
| Avanos Medical | 1 | $15 |
| Zimmer Biomet | 1 | $13 |
| Heraeus Medical, LLC. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REAL INTELLIGENCE$495
- Legion$329
- Journey II$166
- CORI$104
How this compares
$1,265 in reported general payments places this provider in the 25th percentile of 845 orthopaedic surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin | 187 | $214 |
| Meloxicam | 50 | $132 |
| Clindamycin Hcl | 26 | $43 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in New Bern
- Thomas FehringCharlotte$18.3M
- Walter BeaverCharlotte$7.4M
- Robert AndersonCharlotte$6.6M
- William JiranekDurham$6.4M
- John MasonCharlotte$5.7M
- Thomas VailDurham$5.7M
- William DavisCharlotte$5.2M
- John EllingtonCharlotte$4.9M
- Mark EasleyDurham$4M
- Carroll JonesCharlotte$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.